Geneva score

From WikiMD's WELLNESSPEDIA

Geneva Score is a clinical prediction rule used to determine the probability of pulmonary embolism. The score is based on various factors such as age, previous history of deep vein thrombosis or pulmonary embolism, recent surgery or fracture, active malignancy, unilateral lower limb pain, hemoptysis, heart rate, pain on lower limb deep venous palpation and swelling of the entire leg.

Calculation[edit]

The Geneva Score is calculated by assigning points to each of the factors mentioned above. The total score can range from 0 to 25, with higher scores indicating a higher probability of pulmonary embolism.

Use[edit]

The Geneva Score is used in the clinical setting to determine the need for further diagnostic testing in patients with suspected pulmonary embolism. It is particularly useful in patients with a low or intermediate probability of pulmonary embolism.

Limitations[edit]

While the Geneva Score is a useful tool, it is not perfect. It does not take into account all possible risk factors for pulmonary embolism, and it may not be accurate in all patient populations. Furthermore, it should not be used as a substitute for clinical judgment.

See Also[edit]

References[edit]

  • Wicki, J., Perneger, T.V., Junod, A.F., Bounameaux, H., Perrier, A. (2001). Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Archives of Internal Medicine, 161(1), 92-97.



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.